117 related articles for article (PubMed ID: 11396231)
21. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
Hitt R; Jimeno A; Millán JM; Castellano D; Cortés-Funes H
Cancer; 2004 Aug; 101(4):768-75. PubMed ID: 15305408
[TBL] [Abstract][Full Text] [Related]
22. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
23. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F
J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
25. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
26. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS
J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
[TBL] [Abstract][Full Text] [Related]
28. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
29. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
30. Capecitabine and oxaliplatin as second-line treatment in patients with carcinoma of unknown primary site.
Møller AK; Pedersen KD; Abildgaard J; Petersen BL; Daugaard G
Acta Oncol; 2010 May; 49(4):431-5. PubMed ID: 20235750
[TBL] [Abstract][Full Text] [Related]
31. Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
André T; Colin P; Louvet C; Gamelin E; Bouche O; Achille E; Colbert N; Boaziz C; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Billiau V; Buyse M; Gramont A;
Semin Oncol; 2001 Feb; 28(1 Suppl 1):35-40. PubMed ID: 11273588
[TBL] [Abstract][Full Text] [Related]
32. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas.
Chen JS; Jan YY; Lin YC; Wang HM; Chang WC; Liau CT
Anticancer Drugs; 1998 Jun; 9(5):393-7. PubMed ID: 9660535
[TBL] [Abstract][Full Text] [Related]
33. Weekly 24-h infusion of high-dose 5-flurouracil and leucovorin in patients with advanced gastric cancer.
Chen JS; Liu HE; Wang CH; Yang TS; Wang HM; Liau CT; Chang WC; Lin YC
Anticancer Drugs; 1999 Apr; 10(4):355-9. PubMed ID: 10378669
[TBL] [Abstract][Full Text] [Related]
34. A comparison of two dose regimens in pancreatic cancer.
Figer A; Sadikov E; Mishaeli M; Koren R; Gal R; Levin I; Klein B
J Chemother; 2000 Oct; 12(5):442-5. PubMed ID: 11128566
[TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study.
Porta C; Moroni M; Nastasi G; Arcangeli G
Oncology; 1995; 52(6):487-91. PubMed ID: 7478436
[TBL] [Abstract][Full Text] [Related]
36. Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.
Comella P; Palmieri G; Lorusso V; Catalano G; Nicollela D; Ianniello GP; Casaretti R; Montella M; Frasci G; Perna M; Comella G
Eur J Cancer; 1996 Sep; 32A(10):1719-26. PubMed ID: 8983280
[TBL] [Abstract][Full Text] [Related]
37. Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer.
Ahn JB; Shim KY; Jeung HC; Rha SY; Yoo NC; Kim NK; Roh JK; Min JS; Kim BS; Chung HC
Cancer Lett; 2001 Jun; 167(2):215-24. PubMed ID: 11369143
[TBL] [Abstract][Full Text] [Related]
38. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
[TBL] [Abstract][Full Text] [Related]
39. [Palliative treatment with cytostatics of metastatic colorectal cancer in general practice. A model].
Skylstad D; Sørbye H; Småland R
Tidsskr Nor Laegeforen; 1997 Nov; 117(27):3969-72. PubMed ID: 9441425
[TBL] [Abstract][Full Text] [Related]
40. Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam).
Lofts FJ; Gogas H; Mansi JL
Ann Oncol; 1999 Nov; 10(11):1389-92. PubMed ID: 10631472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]